Three‐dimensional conformal radiation therapy for canine aortic body tumour: 6 cases (2014–2019). (10th December 2020) - Maeda, A.
Abstract : Objective: To determine the feasibility of three‐dimensional conformal radiation therapy for canine aortic body tumours. Materials and Methods: Medical records of dogs that had undergone three‐dimensional conformal radiation therapy with presumptive diagnosis of aortic body tumour were reviewed for clinical characteristics, treatment modality and outcomes. Results: Eight dogs were diagnosed with aortic body tumour and were treated with three‐dimensional conformal radiation therapy. One dog had proliferation of a mass in the right atrium during treatment and died of respiratory distress. Another dog did not undergo follow‐up CT to evaluate the treatment response due to the increased blood urea nitrogen values. The remaining 6 dogs were included in the case series. Radiotherapy was performed using a median dose per fraction of 7 Gy (3.3‐7.14 Gy), a median of seven divided doses (7‐15) and a total median dose of 49 Gy (45‐50 Gy). The median number of CT scans during the follow‐up period was 5 (range: 3‐8 times). CT revealed acute side effects in four dogs—grade 1 effects related to the lung (n = 4) and skin (n = 2). Self‐limiting or asymptomatic late side effects (grade 1 lung‐related effect) were observed in three dogs. After therapy, one dog demonstrated a complete response, another demonstrated a partial response and the disease remained stable in four animals. The median follow‐up period was 514.5 (235‐1219) days. After three‐dimensional conformal radiation therapy, the aortic body tumour reduced gradually over time without regrowth in all these 6 dogs. Clinical Significance: In this small case series, aortic body tumours responded to three‐dimensional conformal radiation therapy. Transient and self‐limiting side effects of the treatments were common. Further controlled studies are required to prove the effectiveness and the safety of this intervention.